Alembic Pharmaceuticals Limited (BOM:533573)
India
· Delayed Price · Currency is INR 818.10
-8.10 (-0.98%)
At close: Feb 14, 2025
Alembic Pharmaceuticals Statistics
Total Valuation
BOM:533573 has a market cap or net worth of INR 157.92 billion. The enterprise value is 167.29 billion.
| Market Cap | 157.92B |
| Enterprise Value | 167.29B |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Jul 15, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 57.42M |
Valuation Ratios
The trailing PE ratio is 26.11.
| PE Ratio | 26.11 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 27.66 |
| EV / Sales | 2.61 |
| EV / EBITDA | 16.94 |
| EV / EBIT | 23.28 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.08 |
| Debt / FCF | n/a |
| Interest Coverage | 11.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.94% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.32M |
| Profits Per Employee | 407,013 |
| Employee Count | 14,858 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.88% |
| 50-Day Moving Average | 966.77 |
| 200-Day Moving Average | 1,042.46 |
| Relative Strength Index (RSI) | 22.30 |
| Average Volume (20 Days) | 5,312 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533573 had revenue of INR 64.19 billion and earned 6.05 billion in profits. Earnings per share was 30.71.
| Revenue | 64.19B |
| Gross Profit | 46.96B |
| Operating Income | 7.17B |
| Pretax Income | 6.98B |
| Net Income | 6.05B |
| EBITDA | 9.67B |
| EBIT | 7.17B |
| Earnings Per Share (EPS) | 30.71 |
Balance Sheet
The company has 1.29 billion in cash and 10.66 billion in debt, giving a net cash position of -9.37 billion.
| Cash & Cash Equivalents | 1.29B |
| Total Debt | 10.66B |
| Net Cash | -9.37B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 48.88B |
| Book Value Per Share | 248.21 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.16%, with operating and profit margins of 11.18% and 9.42%.
| Gross Margin | 73.16% |
| Operating Margin | 11.18% |
| Pretax Margin | 10.87% |
| Profit Margin | 9.42% |
| EBITDA Margin | 15.06% |
| EBIT Margin | 11.18% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.35%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.35% |
| Dividend Growth (YoY) | 37.50% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | 1.20% |
| Earnings Yield | 3.83% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |